Rhiannon N. Hardwick

Author

Also Known As

Browuer, Kim L.R., Hardwick, R, Pfeifer, Nathan D., R H Hardwick, RN Hardwick, Rhiannon Hardwick, Rhiannon N Hardwick, Rhiannon N. Hardwick

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Rutgers, The State University of New Jersey Bristol-Myers Squibb (United States)Merck (Germany)Sanofi (United States)

About

Rhiannon N. Hardwick is an author at University of Arizona specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	315
2	Health Sciences	3	3	92
3	Allergy	2	2	39
4	Engineering	1	1	21
5	Public Health	1	1	55

Rhiannon N. Hardwick

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, Drug Metabolism and Disposition	2010	194
Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease April D. Lake, Petr Novák, Craig D. Fisher, Drug Metabolism and Disposition	2011	160
The Adaptive Endoplasmic Reticulum Stress Response to Lipotoxicity in Progressive Human Nonalcoholic Fatty Liver Disease April D. Lake, Petr Novák, Rhiannon N. Hardwick, Toxicological Sciences	2013	140
Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet, Drug Metabolism and Disposition	2011	138
Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease Rhiannon N. Hardwick, Daniel W. Ferreira, Vijay R. More, Drug Metabolism and Disposition	2012	120
Impaired N‐linked glycosylation of uptake and efflux transporters in human non‐alcoholic fatty liver disease John Clarke, Petr Novák, April D. Lake, Liver International	2017	90
Towards in vitro models for reducing or replacing the use of animals in drug testing David M. Stresser, Anna K. Kopec, Philip Hewitt, Nature Biomedical Engineering Animal TestingXenotransplantationPreclinical Drug EvaluationVitro ModelsPharmacology	2023	75
Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis Mark J. Canet, Matthew D. Merrell, Rhiannon N. Hardwick, Drug Metabolism and Disposition	2015	68
Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models Mark J. Canet, Rhiannon N. Hardwick, April D. Lake, Drug Metabolism and Disposition	2014	67
Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis Rhiannon N. Hardwick, Craig D. Fisher, Stephanie M. Street, Drug Metabolism and Disposition	2011	66

Page 1